Niu TK - Search Results

1

Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins.

Niu TK, Princiotta MF, Sei JJ, Norbury CC. Niu TK, et al. Immunohorizons. 2019 Dec 2;3(12):559-572. doi: 10.4049/immunohorizons.1900074. Immunohorizons. 2019. PMID: 31791977 Free article.

2

Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor.

Hu B, Wei Y, Tian L, Zhao X, Lu Y, Wu Y, Yao B, Liu J, Niu T, Wen Y, He Q, Su J, Huang M, Lou Y, Luo Y, Kan B. Hu B, et al. J Immunother. 2005 May-Jun;28(3):236-44. doi: 10.1097/01.cji.0000161394.11831.3f. J Immunother. 2005. PMID: 15838380

3

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.

Su JM, Wei YQ, Tian L, Zhao X, Yang L, He QM, Wang Y, Lu Y, Wu Y, Liu F, Liu JY, Yang JL, Lou YY, Hu B, Niu T, Wen YJ, Xiao F, Deng HX, Li J, Kan B. Su JM, et al. Cancer Res. 2003 Feb 1;63(3):600-7. Cancer Res. 2003. PMID: 12566302

4

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.

Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F. Liu JY, et al. Blood. 2003 Sep 1;102(5):1815-23. doi: 10.1182/blood-2002-12-3772. Epub 2003 May 15. Blood. 2003. PMID: 12750177 Free article.

5

Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.

Hou JM, Liu JY, Yang L, Zhao X, Tian L, Ding ZY, Wen YJ, Niu T, Xiao F, Lou YY, Tan GH, Deng HX, Li J, Yang JL, Mao YQ, Kan B, Wu Y, Li Q, Wei YQ. Hou JM, et al. Oncology. 2005;69(1):81-7. doi: 10.1159/000087303. Epub 2005 Aug 2. Oncology. 2005. PMID: 16088235

6

[Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice].

Niu T, Liu T, Jia YQ, Liu JY, Wu Y, Hu B, Tian L, Yang L, Kan B, Wei YQ. Niu T, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Sep;36(5):661-4, 675. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 16235531 Chinese.

7

[Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].

Wu Y, Yang L, Zhao X, Su JM, Hu B, Liu JY, Niu T, Luo Y, Li Q, Wei YQ. Wu Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Dec;21(6):557-61. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004. PMID: 15583981 Chinese.

8

Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine.

Wu Y, Yang L, Hu B, Liu JY, Su JM, Luo Y, Ding ZY, Niu T, Li Q, Xie XJ, Wen YJ, Tian L, Kan B, Mao YQ, Wei YQ. Wu Y, et al. Anticancer Drugs. 2005 Jun;16(5):551-7. doi: 10.1097/00001813-200506000-00011. Anticancer Drugs. 2005. PMID: 15846121

9

[Prokaryotic expression, purification and identification of recombinant Xenopus laevis and mouse vascular endothelial growth factors].

Niu T, Liu T, Jia YQ, Yang L, Tian L, Liu JY, Hu B, Wu Y, Wei YQ. Niu T, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 May;36(3):301-4. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 15931851 Chinese.

10

Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.

Bai RZ, Wu Y, Liu Q, Xie K, Wei YQ, Wang YS, Liu K, Luo Y, Su JM, Hu B, Liu JY, Li Q, Niu T, Zhao ZW, Yang L. Bai RZ, et al. J Exp Clin Cancer Res. 2009 Mar 5;28(1):31. doi: 10.1186/1756-9966-28-31. J Exp Clin Cancer Res. 2009. PMID: 19265510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters